Day Zero Diagnostics

Developer of genome sequencing-based diagnostics for infectious diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2016 groups52 employees language dayzerodiagnostics.com

Registered entities

Innovation

8 patent families (3 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 288 times.

YearFilings
20191
20203
20212
20223
20232
20254

Investor mix

12 investors on record; lead investors include Golden Seeds, Sands Capital Ventures, Triventures, Sands Capital.

Investor typeCountShare
Venture capital542%
Private equity18%
Accelerator & incubator18%
Other / undisclosed542%
Coming soon